Credit Suisse analyst A.J. Rice lowered the firm’s price target on Labcorp to $231 from $247.41 as the firm updates its model post-Q2 earnings. Credit Suisse keeps an Outperform rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LH:
- Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
- Labcorp price target lowered to $251 from $255 at Baird
- Labcorp price target lowered to $270 from $275 at Truist
- Labcorp cuts FY23 adjusted EPS view to $13.00-$14.00 from $16.25-$17.75
- Labcorp reports Q2 adjusted EPS $3.42, consensus $3.47